Metabolism and function of coenzyme Q

Biochimica et Biophysica Acta - Biomembranes

Volumn 1660, Issue 1-2, 2004, Pages 171-199

  Turunen, Mikael ^a,b   Olsson, Jerker ^b   Dallner, Gustav ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Aging; Antioxidant; Cardiovascular disease; Coenzyme Q; Mevalonate pathway

Indexed keywords

ANTIOXIDANT; MEVALONIC ACID; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR; UBIQUINONE;

ADSORPTION KINETICS; AGING; AMYOTROPHIC LATERAL SCLEROSIS; BACTERIUM; CARDIOMYOPATHY; CELL COMPARTMENTALIZATION; CELL FUNCTION; CELL MEMBRANE; CELL METABOLISM; DEGENERATIVE DISEASE; DIETARY INTAKE; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME METABOLISM; ENZYME MODIFICATION; ENZYME SYNTHESIS; HUMAN; HUNTINGTON CHOREA; INTRACELLULAR TRANSPORT; LYMPHOCYTE; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; MONOCYTE; MUSCLE ATROPHY; NIEMANN PICK DISEASE; NONHUMAN; OXIDATION REDUCTION REACTION; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; REDUCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION; YEAST;

ANIMALIA;

EID: 1642287689     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2003.11.012     Document Type: Article

References (317)

1. Festenstein G.N., Heaton F.W., Lowe J.S., Morton R.A. A constituent of the unsaponifable portion of animal tissue lipids (λmax 272 mμ.). Biochem. J. 59:1955;558-566.
2. Crane F.L., Hatefi Y., Lester R.L., Widmer C. Isolation of a quinone from beef heart mitochondria. Biochim. Biophys. Acta. 25:1957;220-221.
3. Wolf D.E., Hoffman C.H., Trenner N.R., Arison B.H., Shunk C.H., Linn B.O., McPherson J.F., Folkers K. Coenzyme Q. Structure studies on the coenzyme Q group. J. Am. Chem. Soc. 80:1958;4750-4752.
4. Ernster L., Lee I.Y., Norling B., Persson B. Studies with ubiquinone-depleted submitochondrial particles. Essentiality of ubiquinone for the interaction of succinate dehydrogenase, NADH dehydrogenase, and cytochrome b. Eur. J. Biochem. 9:1969;299-310.
5. l complex in the respiratory chain: protonmotive ubiquinone cycle. FEBS Lett. 56:1975;1-6.
6. Schultz B.E., Chan S.I. Structures and proton-pumping strategies of mitochondrial respiratory enzymes. Annu. Rev. Biophys. Biomol. Struct. 30:2001;23-65.
7. Smeitink J., van den Heuvel L., DiMauro S. The genetics and pathology of oxidative phosphorylation. Nat. Rev., Genet. 2:2001;342-352.
8. Heales S.J.R., Gregg M.E., Clarke J.B. Oxidative phosphorylation: structure, function, and intermediary metabolism. Int. Rev. Neurobiol. 53:2002;25-56.
9. Lenaz G., Bovina C., Pich M.M., D'Aurelio M., Fato R., Formiggini G., Genova M.L., Guiliano G., Paolucci U., Castelli G.P., Ventura B. Role of mitochondria in oxidative stress and aging. Ann. N.Y. Acad. Sci. 959:2002;199-213.
10. DeHahn T., Barr R., Morré D.J. NADH oxidase activity present on both the external and internal surfaces of soybean plasma membranes. Biochim. Biophys. Acta. 1328:1997;99-108.
11. Brightman A.O., Wang J., Miu R.K., Sun I.L., Barr R., Crane F.L., Morré D.J. A growth factor- and hormone-stimulated NADH oxidase from rat liver plasma membrane. Biochim. Biophys. Acta. 1105:1992;109-117.
12. Morré D.J. The hormone- and growth factor-stimulated NADH oxidase. J. Bioenerg. Biomembranes. 26:1994;421-433.
13. ·- generating oxidase from human neutrophils. Identification of a flavoprotein component that is deficient in a patient with chronic granulomatous disease. J. Biol. Chem. 258:1983;6352-6356.
14. Kishi T., Morré D.M., Morré D.J. The plasma membrane NADH oxidase of HeLa cells has hydroquinone oxidase activity. Biochim. Biophys. Acta. 1412:1999;66-77.
15. Sun I.L., Sun E.E., Crane F.L., Morré D.J., Lindgren A., Löw H. Requirement for coenzyme Q in plasma membrane electron transport. Proc. Natl. Acad. Sci. U. S. A. 89:1992;11126-11130.
16. Chueh P.J., Morré D.M., Penel C., DeHahn T., Morré D.J. The hormone-responsive NADH oxidase of the plant plasma membrane has properties of a NADH:protein disulfide reductase. J. Biol. Chem. 272:1997;11221-11227.
17. Gómez-Díaz C., Rodríguez-Aguilera J.C., Barroso M.P., Villalba J.M., Navaro F., Crane F.L., Navas P. Antioxidant ascorbate is stabilized by NADH-coenzyme Q10 reductase in the plasma membrane. J. Bioenerg. Biomembranes. 29:1997;251-257.
18. Crane F.L., Sun I.L., Clark M.G., Grebing C., Löw H. Transplasma membrane redox systems in growth and development. Biochim. Biophys. Acta. 811:1985;233-264.
19. Burón M.I., Rodríguez-Agluilera J.C., Alcaín F.J., Navas P. Transplasma membrane redox system in HL-60 cells is modulated during TPA-induced differentiation. Biochem. Biophys. Res. Commun. 192:1993;439-445.
20. Larm J.A., Vaillant F., Linnane A.W., Lawen A. Up-regulation of the plasma membrane oxidoreductase as a prequisite for the viability of human Namalwa ρ0 cells. J. Biol. Chem. 269:1994;30097-30100.
21. Lawen A., Martinus R.D., McMullen G.L., Nagley P., Vaillant F., Wolvetang E.J., Linnane A.W. The universality of bioenergetic disease: the role of mitochondrial mutation and the putative inter-relationship between mitochondria and plasma membrane NADH oxidoreductase. Mol. Aspects Med. 15:1994;13-27.
22. Crane F.L., Sun I.L., Crowe R.A., Alcain F.J., Löw H. Coenzyme Q10, plasma membrane oxidase and growth control. Mol. Aspects Med. 15:1994;1-11.
23. Iuchi S., Lin E.C. Adaptation of Escherichia coli to respiratory conditions: regulation of a gene expression. Cell. 66:1991;5-7.
24. Shibunama M., Kuroki T., Nose K. Stimulation by hydrogen peroxide of DNA synthesis, competence family gene expression and phosphorylation of specific protein in quiescent Balb/3T3 cells. Oncogene. 5:1990;1025-1032.
25. Stirpe F., Higgins T., Tazzari P.L., Rozengurt E. Stimulation by xanthine oxidase of 3T3 Swiss fibroblasts and human lymphocytes. Exp. Cell Res. 192:1991;635-638.
26. Gille L., Nohl H. The existence of a lysosomal redox chain and the role of ubiquinone. Arch. Biochem. Biophys. 375:2000;347-354.
27. Papa S. Mitochondrial oxidative phosphorylation changes in the life span. Molecular aspects and physiopathological implications. Biochim. Biophys. Acta. 1276:1996;87-105.
28. Rolfe D.F., Brown G.C. Cellular energy utilization and molecular origin of standard metabolic rate in mammals. Physiol. Rev. 77:1997;731-758.
29. Papa S., Skulachev V.P. Reactive oxygen species, mitochondria, apoptosis and aging. Mol. Cell. Biochem. 174:1997;305-319.
30. Skulachev V.P. Uncoupling: new approaches to an old problem of bioenergetics. Biochim. Biophys. Acta. 1363:1998;100-124.
31. Cadenas E., Davis K.J.A. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic. Biol. Med. 29:2000;222-230.
32. Chance B., Sies H., Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59:1979;527-605.
33. Halliwell B., Cutteridge J.M.C. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem. J. Retat. Areas Mol. Biol. 219:1984;1-14.
34. Cadenas E., Hochstein P., Ernster L. Pro- and antioxidant functions of quinones and quinone reductases in mammalian cells. Adv. Enzymol. 65:1992;97-146.
35. van Kuijk F.J.M.G., Sevanian A., Handelman G.J., Dratz E.A. A new role for phosopholipase A2: protection of membranes from lipid peroxidation damage. Trends Biochem. Sci. 12:1987;31-33.
36. Brigelius-Flohé R. Tissue-specific functions of individual glutathione peroxidases. Free Radic. Biol. Med. 27:1999;951-965.
37. Stadtman E.R. Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences. Free Radic. Biol. Med. 9:1990;315-325.
38. Stadtman E.R., Berlett B.S. Fenton chemistry. Amino acid oxidation. J. Biol. Chem. 266:1991;17201-17211.
39. Forsmark-Andrée P., Dallner G., Ernster L. Endogenous ubiquinol prevents protein modification accompanying lipid peroxidation in beef heart submitochondrial particles. Free Radic. Biol. Med. 19:1995;749-757.
40. Grune T., Reinheckel T., Davis K.J.A. Degradation of oxidized proteins in mammalian cells. FASEB J. 11:1997;526-534.
41. Ullrich O., Reinheckel T., Sitte N., Hass R., Grune T., Davis K.J.A. Poly-ADP ribose polymerase activates nuclear proteasome to degrade oxidatively damaged histones. Proc. Natl. Acad. Sci. U. S. A. 96:1999;6223-6228.
42. Halliwell B., Auroma O.I. DNA damage by oxygen-derived species. Its mechanism and measurement in mammalian systems. FEBS Lett. 281:1991;9-19.
43. Ozawa T. Genetic and functional changes in mitochondria associated with aging. Physiol. Rev. 77:1997;425-464.
44. Wood R.D. DNA repair in eukaryotes. Annu. Rev. Biochem. 65:1996;135-167.
45. Holmgren A., Björnstedt M. Thioredoxin and thioredoxin reductase. Methods Enzymol. 252:1995;199-208.
46. Wood Z.A., Poole L.B., Karplus P.A. Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling. Science. 300:2003;650-653.
47. Mellors A., Tappel A.L. The inhibition of mitochondrial peroxidation by ubiquinone and ubiquinol. J. Biol. Chem. 241:1966;4353-4356.
48. Takayanagi R., Takeshige K., Minakami S. NADH- and NADPH-dependent lipid peroxidation in bovine heart submitochondrial particles. Dependence on the rate of electron flow in the respiratory chain and an antioxidant role of ubiquinol. Biochem. J. 192:1980;853-860.
49. Ernster L., Dallner G. Biochemical, physiological and medical aspects of ubiquinone function. Biochim. Biophys. Acta. 1271:1995;195-204.
50. Romagnoli A., Oradei A., Destito C., Iacocagni A., Marin A.W., Littarru G.P. Protective role in vivo of coenzyme Q10 during reperfusion of ischemic limbs. Mol. Aspects Med. 15:1994;177-185.
51. Alleva R., Tomasetti M., Battino M., Curatola G., Littarru G.P., Folkers K. The roles of coenzyme Q10 and vitamin E on the peroxidation of human low density lipoprotein subfractions. Proc. Natl. Acad. Sci. U. S. A. 92:1995;9388-9391.
52. Åberg F., Appelkvist E.L., Dallner G., Ernster L. Distribution and redox state of ubiquinones in rat and human tissues. Arch. Biochem. Biophys. 295:1992;230-234.
53. Ernster L., Forsmark-Andree P. Ubiquinol: an endogenous antioxidant in aerobic organisms. Clin. Investig. 71:1993;60-65.
54. Frei B., Kim M.C., Ames B.N. Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations. Proc. Natl. Acad. Sci. U. S. A. 87:1990;4879-4883.
55. Shi H., Noguchi N., Niki E. Comparative study on dynamics of antioxidative action of alpha-tocopheryl hydroquinone, ubiquinol, and alpha-tocopherol against lipid peroxidation. Free Radic. Biol. Med. 27:1999;334-346.
56. Stocker R., Bowry V.W., Frei B. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol. Proc. Natl. Acad. Sci. U. S. A. 88:1991;1646-1650.
57. Thomas S.R., Neuzil J., Mohr D., Stocker R. Co-antioxidants make α-tocopherol an efficient antioxidant for low-density lipoprotein. Am. J. Clin. Nutr. 62:1995;1357-1364.
58. Forsmark P., Åberg F., Norling B., Nordenbrand K., Dallner G., Ernster L. Inhibition of lipid peroxidation by ubiquinol in submitochondrial particles in the absence of vitamin E. FEBS Lett. 285:1991;39-43.
59. Forsmark-Andrée P., Persson B., Radi R., Dallner G., Ernster L. Oxidative modification of nicotinamide nucleotide transhydrogenase in submitochondrial particles: effect of endogenous ubiquinol. Arch. Biochem. Biophys. 336:1996;113-120.
60. Forsmark-Andrée P., Lee C.P., Dallner G., Ernster L. Lipid peroxidation and changes in the ubiquinone content and the respiratory chain enzymes of submitochondrial particles. Free Radic. Biol. Med. 22:1997;391-400.
61. Tomasetti M., Littarru G.P., Stocker R., Alleva R. Coenzyme Q10 enrichment decreases oxidative DNA damage in human lymphocytes. Free Radic. Biol. Med. 27:1999;1027-1032.
62. Tomasetti M., Alleva R., Borghi B., Collins A.R. In vivo supplementation with coenzyme Q10 enhances the recovery of human lymphocytes from oxidative DNA damage. FASEB J. 15:2001;1425-1427.
63. Hundal T., Forsmark-Andrée P., Ernster L., Andersson B. Antioxidant activity of reduced plastoquinone in chloroplast thylakoid membranes. Arch. Biochem. Biophys. 324:1995;117-122.
64. Nicholls D.G., Locke R.M. Thermogenic mechanisms in brown fat. Physiol. Rev. 64:1984;1-64.
65. Nedergaard J., Cannon B. The uncoupling protein thermogenin and mitochondrial thermogenesis. New Compr. Biochem. 23:1992;385-420.
66. Klingenberg M., Huang S.G. Structure and function of the uncoupling protein from brown adipose tissue. Biochim. Biophys. Acta. 1415:1999;271-296.
67. Klingenberg M., Echtay K.S. Uncoupling proteins: the issues from a biochemist point of view. Biochim. Biophys. Acta. 1504:2001;128-143.
68. Nedergaard J., Golozoubova V., Matthias A., Asadi A., Jacobsson A., Cannon B. UCP1: the only protein able to mediate adaptive non-shivering thermogenesis and metabolic inefficiency. Biochim. Biophys. Acta. 1504:2001;82-106.
69. Pecqueur C., Couplan E., Bouillaud F., Ricquier D. Genetic and physiological analysis of the role of uncoupling proteins in human energy homeostasis. J. Mol. Med. 79:2001;48-56.
70. Echtay K.S., Winkler E., Klingenberg M. Coenzyme Q is an obligatory cofactor for uncoupling protein function. Nature. 408:2000;609-613.
71. Echtay K.S., Winkler E., Frischmuth K., Klingenberg M. Uncoupling proteins 2 and 3 are highly active H+ transporters and highly nucleotide sensitive when activated by coenzyme Q (ubiquinone). Proc. Natl. Acad. Sci. U. S. A. 98:2001;1416-1421.
72. Fontaine E., Bernardi P. Progress on the mitochondrial permeability transition pore: Regulation by complex I and ubiquinone analogs. J. Bioenerg. Biomembranes. 31:1999;335-345.
73. Green D.R., Reed J.C. Mitochondria and apoptosis. Science. 281:1998;1309-1312.
74. Ichas F., Jouaville L.S., Mazat J.P. Mitochondria are excitable organelles capable of generating and conveying electrical and calcium signals. Cell. 89:1997;1145-1153.
75. Petronilli V., Miotto G., Canton M., Brini M., Colonna R., Bernardi P., Di Lisa F. Transient and long-lasting openings of the mitochondrial permeability transition pore can be monitored directly in intact cells by changes in mitochondrial calcein fluorescence. Biophys. J. 76:1999;725-734.
76. Fontaine E., Ichas F., Bernardi P. A ubiquinone-binding site regulates the mitochondrial permeability transition pore. J. Biol. Chem. 273:1998;25734-25740.
77. Walter L., Nogueira V., Leverve X., Heitz M.P., Bernardi P., Fontaine E. Three classes of ubiquinone analogs regulate the mitochondrial permeability transition pore through a common site. J. Biol. Chem. 275:2000;29521-29527.
78. Walter L., Miyoshi H., Leverve X., Bernardi P., Fontaine E. Regulation of the mitochondrial permeability transition pore by ubiquinone analogs, A progress report. Free Radic. Res. 36:2002;405-412.
79. Papucci L., Schiavone N., Witort E., Donnini M., Lapucci A., Tempestini A., Formigli L., Orlandini S.Z., Orlandini G., Carella G., Brancato R., Capaccioli S. Coenzyme Q10 prevents apoptosis by inhibiting mitochondrial depolarization independently of its free radical scavenging property. J. Biol. Chem. 278:2003;28220-28228.
80. Folkers K., Hanioka T., Xia L.J., McRee J.T., Langsjoen P. Coenzyme Q10 increases T4/T8 ratios of lymphocytes in ordinary subjects and relevance to patients having the AIDS related complex. Biochem. Biophys. Res. Commun. 176:1991;786-791.
81. Folkers K., Morita M., McRee J. The activities of coenzyme Q10 and vitamin B6 for immune responses. Biochem. Biophys. Res. Commun. 193:1993;88-92.
82. Barbieri B., Lund B., Lundström B., Scaglione F. Coenzyme Q10 administration increases antibody titer in hepatitis B vaccinated volunteers - A single blind placebo-controlled and randomized clinical study. Biofactors. 9:1999;351-357.
83. Ravaglia G., Forti P., Maioli F., Bastagli L., Facchini A., Mariani E., Savarino L., Sassi S., Cucinotta D., Lenaz G. Effect of micronutrient status on natural killer cell immune function in healthy free-living subjects aged ≥90 y. Am. J. Clin. Nutr. 71:2000;590-598.
84. Smith J.D., Trogan E., Ginsberg M., Grigaux C., Tian J., Miyata M. Decreased atherosclerosis in mice deficient in both macrophage colony stimulating factor (op) and apolipoprotein E. Proc. Natl. Acad. Sci. U. S. A. 92:1995;8264-8268.
85. Qiao J.H., Tripathi J., Mishra N.K., Cai Y., Tripathi S., Wang X.P., Imes S., Fishbein M.C., Clinton S.K., Libby P., Lusis A.J., Rajavashisth T.B. Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteoporotic mice. Am. J. Pathol. 150:1997;1687-1699.
86. Adams D.H., Shaw S. Leucocyte-endothelial interactions and regulation of leucocyte migration. Lancet. 343:1994;831-836.
87. Hubbard A.K., Rothlein R. Intracellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades. Free Radic. Biol. Med. 28:2000;1379-1386.
88. Turunen M., Wehlin L., Sjöberg M., Lundahl J., Dallner G., Brismar K., Sindelar P.J. beta2-Integrin and lipid modifications indicate a non-antioxidant mechanism for the anti-atherogenic effect of dietary coenzyme Q10. Biochem. Biophys. Res. Commun. 296:2002;255-260.
89. Witting P.K., Pettersson K., Letters J., Stocker R. Anti-atherogenic effect of coenzyme Q10 in apolipoprotein E gene knockout mice. Free Radic. Biol. Med. 29:2000;295-305.
90. Thomas S.R., Leichtweis S.B., Pettersson K., Croft K.D., Mori T.A., Brown A.J., Stocker R. Dietary cosupplementation with vitamin E and coenzyme Q(10) inhibits atherosclerosis in apolipoprotein E gene knockout mice. Arterioscler. Thromb. Vasc. Biol. 21:2001;585-593.
91. Calles-Escandon J., Cipolla M. Diabetes and endothelial dysfunction: a clinical perspective. Endocrine Rev. 22:2001;36-52.
92. Watts G.F., Playford D.A., Croft K.D., Ward N.C., Mori T.A., Burke V. Coenzyme Q(10) improves endothelial dysfunction of the brachial artery in type II diabetes mellitus. Diabetologia. 45:2002;420-426.
93. Hodgson J.M., Watts G.F., Playford D.A., Burke V., Croft K.D. Coenzyme Q10 improves blood pressure and glycaemic control: a controlled clinical trial in subjects with type 2 diabetes. Eur. J. Clin. Nutr. 56:2002;1137-1142.
94. Tomasetti M., Alleva R., Solenghi M.D., Littarru G.P. Distribution of antioxidants among blood components and lipoproteins: significance of lipids/CoQ10 ratio as a possible marker of increased risk for atherosclerosis. Biofactors. 9:1999;231-240.
95. Yamamoto Y., Yamashita S. Plasma ubiquinone ratio in patients with hepatitis, cirrhosis, and hepatoma, and in patients treated with percutaneous transluminal coronary reperfusion. Biofactors. 9:1999;241-246.
96. Runquist M., Parmryd I., Thelin A., Chojnacki T., Dallner G. Distribution of branch point prenyltransferases in regions of bovine brain. J. Neurochem. 65:1995;2299-2306.
97. Chojnacki T., Dallner G. The biological role of dolichol. Biochem. J. 251:1988;1-9.
98. Matsura T., Yamada K., Kawasaki T. Changes in the content and intracellular distribution of coenzyme Q homologs in rabbit liver during growth. Biochim. Biophys. Acta. 1083:1991;277-282.
99. Zhang Y., Appelkvist E.L., Kristensson K., Dallner G. The lipid compositions of different regions of rat brain during development and aging. Neurobiol. Aging. 17:1996;869-875.
100. Lenaz G., Daves D.G., Folkers K. Organic structural specificity and sites of coenzyme Q in succinoxidase and DPNH-oxidase systems. Arch. Biochem. Biophys. 123:1968;539-550.
101. Kagan V.E., Serbinova E.A., Koynova G.M., Kitanova S.A., Tyurin V.A., Stoytchev T.S., Quinn P.J., Packer L. Antioxidant action of ubiquinol homologues with different isoprenoid chain length in biomembranes. Free Radic. Biol. Med. 9:1990;117-126.
102. Lenaz G. Quinone specificity of complex I. Biochim. Biophys. Acta. 1364:1998;207-221.
103. Lass A., Agarwal S., Sohal R.S. Mitochondrial ubiquinone homologues, superoxide radical generation, and longevity in different mammalian species. J. Biol. Chem. 272:1997;19199-19204.
104. Edlund C., Holmberg K., Dallner G., Norrby E., Kristensson K. Ubiquinone-10 protects neurons from virus-induced degeneration. J. Neurochem. 63:1994;634-639.
105. Valtersson C., van Duyn G., Verkleij A.J., Chojnacki T., de Kruijff B., Dallner G. The influence of dolichol, dolichol esters and dolichyl phosphate on phospholipid polymorphism and fluidity in model membranes. J. Biol. Chem. 260:1985;2742-2751.
106. Cornell B.A., Keniry M.A., Post A., Robertson R.N., Weir L.E., Westerman P.W. Location and activity of ubiquinone 10 and ubiquinone analogues in model and biological membranes. Biochemistry. 26:1987;7702-7707.
107. van Duijn G., Verkleij A.J., de Kruijff B., Valtersson C., Dallner G., Chojnacki T. Influence of dolichols on lipid polymorphism in model membranes and the consequences for phospholipid flip-flop and vesicle fusion. Chem. Scr. 27:1987;95-100.
108. Lenaz G., Samori B., Fato R., Battino M., Parenti Castelli G., Domini I. Localization and preferred orientations of ubiquinone homologs in model bilayers. Biochem. Cell. Biol. 70:1992;504-514.
109. van Dijck P.W., de Kruijff B., van Deenen L.L., de Gier J., Demel R.A. The preference of cholesterol for phosphatidylcholine in mixed phosphatidylcholine-phosphatidylethanolamine bilayers. Biochim. Biophys. Acta. 455:1976;576-587.
110. Löw P., Peterson E., Edlund C., Brunk U., Appelkvist E.L. Nonmembrane associated dolichol in rat liver. Lipids. 27:1992;1-9.
111. Bentinger M., Dallner G., Chojnacki T., Swiezewska E. Distribution and breakdown of labeled coenzyme Q(10) in rat. Free Radic. Biol. Med. 34:2003;563-575.
112. Kalen A., Norling B., Appelkvist E.L., Dallner G. Ubiquinone biosynthesis by the microsomal fraction from rat liver. Biochim. Biophys. Acta. 926:1987;70-78.
113. Jakobsson-Borin Å., Åberg F., Dallner G. Lipid peroxidation of microsomal and mitochondrial membranes extracted with n-pentane and reconstituted with ubiquinol, dolichol and cholesterol. Biochim. Biophys. Acta. 1213:1994;159-166.
114. Belogrudov G.I., Lee P.T., Jonassen T., Hsu A.Y., Gin P., Clarke C.F. Yeast COQ4 endocodes a mitochondrial protein required for coenzyme Q synthesis. Arch. Biochem. Biophys. 392:2001;48-58.
115. Jonassen T., Clarke C.F. Isolation and functional expression of human COQ3, a gene encoding a methyltransferase required for ubiquinone biosynthesis. J. Biol. Chem. 275:2000;12381-12387.
116. Vajo Z., King L.M., Jonassen T., Wilkin D.J., Ho N., Munnich A., Clarke C.F., Francomano C.A. Conservation of the Caenorhabditis elegans timing gene clk-1 from yeast to human: a gene required for ubiquinone biosynthesis with potential implications for aging. Mamm. Genome. 10:1999;1000-1004.
117. Grünler J., Ericsson J., Dallner G. Branch-point reactions in the biosynthesis of cholesterol, dolichol, ubiquinone and prenylated proteins. Biochim. Biophys. Acta. 1212:1994;259-277.
118. Brown M.S., Goldstein J.L. A receptor-mediated pathway for cholesterol homeostasis. Science. 232:1986;34-47.
119. Alberts A.W. Discovery, biochemistry and biology of lovastatin. Am. J. Cardiol. 62:1988;10-15.
120. Edwards P.A., Lan S.F., Fogelman A.M. Alterations in the rates of synthesis and degradation of rat liver 3-hydroxy-3-methylglutaryl coenzyme A reductase produced by cholestyramine and mevinolin. J. Biol. Chem. 258:1983;10219-10222.
121. Clarke C.F., Fogelman A.M., Edwards P.A. Diurnal rhythm of rat liver mRNAs encoding 3-hydroxy-3-methylglutaryl coenzyme A reductase. Correlation of functional and total mRNA levels with enzyme activity and protein. J. Biol. Chem. 259:1984;10439-10447.
122. Goldstein J.L., Brown M.S. Regulation of the mevalonate pathway. Nature. 343:1990;425-430.
123. Clarke P.R., Hardie D.G. Regulation of HMG-CoA reductase: identification of the site phosphorylated by the AMP-activated protein kinase in vitro and in intact rat liver. EMBO J. 9:1990;2439-2446.
124. Cuthbert J.A., Lipsky P.E. Negative regulation of cell proliferation by mevalonate or one of the mevalonate phosphates. J. Biol. Chem. 266:1991;17966-17971.
125. Warner G.J., Berry M.J., Moustafa M.E., Carlson B.A., Hatfield D.L., Faust J.R. Inhibition of selenoprotein synthesis by selenocysteine tRNA[Ser]Sec lacking isopentenyladenosine. J. Biol. Chem. 275:2000;28110-28119.
126. Driscoll D.M., Copeland P.R. Mechanism and regulation of selenoprotein synthesis. Annu. Rev. Nutr. 23:2003;17-40.
127. Rilling H.C. Eukaryotic prenyltransferases. Methods Enzymol. 110:1985;145-152.
128. Teclebrhan H., Olsson J., Swiezewska E., Dallner G. Biosynthesis of the side chain of ubiquinone: trans-prenyltransferase in rat liver microsomes. J. Biol. Chem. 268:1993;23081-23086.
129. Swiezewska E., Dallner G., Andersson B., Ernster L. Biosynthesis of ubiquinone and plastoquinone in the endoplasmic reticulum-Golgi membranes of spinach leaves. J. Biol. Chem. 268:1993;1494-1499.
130. Rosser D.S., Ashby M.N., Ellis J.L., Edwards P.A. Coordinate regulation of 3-hydroxy-3-methylglutaryl-coenzyme A synthase, 3-hydroxy-3-methylglutaryl- coenzyme A reductase, and prenyltransferase synthesis but not degradation in HepG2 cells. J. Biol. Chem. 264:1989;12653-12656.
131. Andersson M., Ericsson J., Appelkvist E.L., Schedin S., Chojnacki T., Dallner G. Modulations in hepatic branch-point enzymes involved in isoprenoid biosynthesis upon dietary and drug treatments of rats. Biochim. Biophys. Acta. 1214:1994;79-87.
132. Wang K., Ohnuma S. Chain-length determination mechanism of isoprenyl diphosphate synthases and implications for molecular evolution. Trends Biochem. Sci. 24:1999;445-451.
133. Ogura K., Koyama T. Enzymatic aspects of isoprenoid chain elongation. Chem. Rev. 98:1998;1263-1276.
134. Okada K., Suzuki K., Kamiya Y., Zhu X., Fujisaki S., Nishimura Y., Nishino T., Nakagawa T., Kawamukai M., Matsuda H. Polyprenyl diphosphate synthase essentially defines the length of the side chain of ubiquinone. Biochim. Biophys. Acta. 1302:1996;217-223.
135. Ohnuma S., Nakazawa T., Hemmi H., Hallberg A.M., Koyama T., Ogura K., Nishino T. Conversion from farnesyl diphosphate synthase to geranylgeranyl diphosphate synthase by random chemical mutagenesis. J. Biol. Chem. 271:1996;10087-10095.
136. Ohnuma S., Hirooka K., Hemmi H., Ishida C., Ohto C., Nishino T. Conversion of product specificity of archaebacterial geranylgeranyl-diphosphate synthase. Identification of essential amino acid residues for chain length determination of prenyltransferase reaction. J. Biol. Chem. 271:1996;18831- 18837.
137. Teclebrhan H., Jakobsson-Borin A., Brunk U., Dallner G. Relationship between the endoplasmic reticulum-Golgi membrane system and ubiquinone biosynthesis. Biochim. Biophys. Acta. 1256:1995;157-165.
138. Olson R.E., Rudney H. Biosynthesis of ubiquinone. Vitam. Horm. 40:1983;1-43.
139. Ranganathan S., Ramasarma T. The regulation of the biosynthesis of ubiquinone in the rat. Biochem. J. 148:1975;35-39.
140. Ashby M.N., Kutsunai S.Y., Ackerman S., Tzagoloff A., Edwards P.A. COQ2 is a candidate for the structural gene encoding para-hydroxybenzoate: polyprenyltransferase. J. Biol. Chem. 267:1992;4128-4136.
141. Melzer M., Heide L. Characterization of polyprenyldiphosphate:4- hydroxybenzoate polyprenyltransferase from Escherichia coli. Biochim. Biophys. Acta. 1212:1994;93-102.
142. Alam S.S., Nambudiri A.M., Rudney H. 4-Hydroxybenzoate:polyprenyl transferase and the prenylation of 4-aminobenzoate in mammalian tissues. Arch. Biochem. Biophys. 171:1975;183-190.
143. Momose K., Rudney H. 3-Polyprenyl-4-hydroxybenzoate synthesis in the inner membrane of mitochondria from p-hydroxybenzoate and isopentenylpyrophosphate. A demonstration of isoprenoid systhesis in rat liver mitochondria. J. Biol. Chem. 247:1972;3930-3940.
144. Nambudiri A.M., Brockman D., Alam S.S., Rudney H. Alternate routes for ubiquinone biosynthesis in rats. Biochem. Biophys. Res. Commun. 76:1976;282-287.
145. Kalen A., Appelkvist E.L., Chojnacki T., Dallner G. Nonaprenyl-4- hydroxybenzoate transferase, an enzyme involved in ubiquinone biosynthesis, in the endoplasmic reticulum-Golgi system of rat liver. J. Biol. Chem. 265:1990;1158-1164.
146. Dialameh G.H., Nowicki H.G., Yekundi K.G., Olson R.E. Involvement of p-OH-benzoyl-coenzyme A in the biosynthesis of ubiquinone-9 in the rat. Biochem. Biophys. Res. Commun. 40:1970;1063-1069.
147. Kang D., Takeshige K., Isobe R., Minakami S. Evidence that the decarboxylation reaction occurs before the first methylation in ubiquinone biosynthesis in rat liver mitochondria. Eur. J. Biochem. 198:1991;599-605.
148. Tzagoloff A., Dieckmann C.L. PET genes of Saccharomyces cerevisiae. Microbiol. Rev. 54:1990;211-225.
149. Clarke C.F., Williams W., Teruya J.H. Ubiquinone biosynthesis in Saccharomyces cerevisiae. Isolation and sequence of COQ3, the 3,4-dihydroxy-5-hexaprenylbenzoate methyltransferase gene. J. Biol. Chem. 266:1991;16636-16644.
150. Wu G., Williams H.D., Zamanian M., Gibson F., Poole R.K. Isolation and characterization of Escherichia coli mutants affected in aerobic respiration: The cloning and nucleotide sequence of ubiG. Identification of an S-adenosylmethionine-binding motif in protein, RNA, and small molecule methyltransferases. J. Gen. Microbiol. 138:1992;2101-2112.
151. Kagan R.M., Clarke S. Widespread occurrence of three sequence motifs in diverse S-adenosylmethionine-dependent methyltransferases suggests a common structure for these enzymes. Arch. Biochem. Biophys. 310:1994;417-427.
152. Niewmierzycka A., Clarke S. S-Adenosylmethionine-dependent methylation in Saccharomyces cerevisiae. Identification of a novel protein originine methyltransferase. J. Biol. Chem. 274:1999;814-824.
153. Marbois B.N., Hsu A., Pillai R., Colicelli J., Clarke C.F. Cloning of a rat cDNA encoding dihydroxypolyprenylbenzoate methyltransferase by functional complementation of a Saccharomyces cerevisiae mutant deficient in ubiquinone biosynthesis. Gene. 138:1994;213-217.
154. Marbois B.N., Xia Y.R., Lusis A.J., Clarke C.F. Ubiquinone biosynthesis in eukaryotic cells: tissue distribution of mRNA encoding 3,4-dihydroxy-5- polyprenylbenzoate methyltransferase in the rat and mapping of the COQ3 gene to mouse chromosome 4. Arch. Biochem. Biophys. 313:1994;83-88.
155. Hsu A.Y., Poon W.W., Shepherd J.A., Myles D.C., Clarke C.F. Complementation of coq3 mutant yeast by mitochondrial targeting of the Escherichia coli UbiG polypeptide: evidence that UbiG catalyzes both O-methylation steps in ubiquinone biosynthesis. Biochemistry. 35:1996;9797-9806.
156. Poon W.W., Barkovich R.J., Hsu A.Y., Frankel A., Lee P.T., Shepherd J.N., Myles D.C., Clarke C.F. Yeast and rat Coq3 and Escherichia coli UbiG polypeptides catalyze both O-methyltransferase steps in coenzyme Q biosynthesis. J. Biol. Chem. 274:1999;21665-21672.
157. Marbois B.N., Clarke C.F. The COQ7 gene encodes a protein in Saccharomyces cerevisiae necessary for ubiquinone biosynthesis. J. Biol. Chem. 271:1996;2995-3004.
158. Proft M., Kotter P., Hedges D., Bojunga N., Entian K.D. CAT5, a new gene necessary for derepression of gluconeogenic enzymes in Saccharomyces cerevisiae. EMBO J. 14:1995;6116-6126.
159. Jonassen T., Proft M., Randez-Gil F., Schultz J.R., Marbois B.N., Entian K.D., Clarke C.F. Yeast Clk-1 homologue (Coq7/Cat5) is a mitochondrial protein in coenzyme Q synthesis. J. Biol. Chem. 273:1998;3351-3357.
160. Jonassen T., Marbois B.N., Kim L., Chin A., Xia Y.-R., Lusis A.J., Clarke C.F. Isolation and sequencing of the rat Coq7 gene and the mapping of mouse Coq7 to chromosome 7. Arch. Biochem. Biophys. 330:1996;285-289.
161. Ewbank J.J., Barnes T.M., Lakowski B., Lussier M., Bussey H., Hekimi S. Structural and functional conservation of the Caenorhabditis elegans timing gene clk-1. Science. 275:1997;980-983.
162. Jonassen T., Larsen P.L., Clarke C.F. A dietary source of coenzyme Q is essential for growth of long-lived Caenorhabditis elegans clk-1 mutants. Proc. Natl. Acad. Sci. U. S. A. 98:2001;421-426.
163. Jiang N., Levavasseur F., McCright B., Shoubridge E.A., Hekimi S. Mouse CLK-1 is imported into mitochondria by an unusual process that requires leader sequence but no membrane potential. J. Biol. Chem. 276:2001;29218-29225.
164. Wong A., Boutis P., Hekimi S. Mutations in the clk-1 gene of Caenorhabditis elegans affect developmental and behavioral timing. Genetics. 139:1995;1247-1259.
165. Gin P., Hsu A.Y., Rothman S.C., Jonassen T., Lee P.T., Tzagoloff A., Clarke C.F. The Saccharomyces cerevisiae COQ6 gene encodes a mitochondrial flavin-dependent monooxygenase required for coenzyme Q biosynthesis. J. Biol. Chem. 278:2003;25308-25316.
166. Do T.Q., Hsu A.Y., Jonassen T., Lee P.T., Clarke C.F. A defect in coenzyme Q biosynthesis is responsible for the respiratory deficiency in Saccharomyces cerevisiae abc1 mutants. J. Biol. Chem. 276:2001;18161-18168.
167. Poon W.W., Davis D.E., Ha H.T., Jonassen T., Rather P.N., Clarke C.F. Identification of Escherichia coli ubiB, a gene required for the first monooxygenase step in ubiquinone biosynthesis. J. Bacteriol. 182:2000;5139-5146.
168. Hsu A.Y., Do T.Q., Lee P.T., Clarke C.F. Genetic evidence for a multi-subunit complex in the O-methyltransferase steps of coenzyme Q biosynthesis. Biochim. Biophys. Acta. 1484:2000;287-297.
169. Yamamoto T., Shimizu S., Sugawara H., Momose K., Rudney H. Identification of regulatory sites in the biosynthesis of ubiquinone in the perfused rat heart. Arch. Biochem. Biophys. 269:1989;86-92.
170. Yamamoto T., Sugawara H., Shimizu S., Momose K. Possible existence of an
171. Elmberger P.G., Kalen A., Brunk U.T., Dallner G. Discharge of newly-synthesized dolichol and ubiquinone with lipoproteins to rat liver perfusate and to the bile. Lipids. 24:1989;919-930.
172. Wüstner D., Herrmann A., Hao M., Maxfield F.R. Rapid nonvesicular transport of sterol between the plasma membrane domains of polarized hepatic cells. J. Biol. Chem. 277:2002;30325-30336.
173. Wanke M., Dallner G., Swiezewska E. Subcellular localization of plastoquinone and ubiquinone synthesis in spinach cells. Biochim. Biophys. Acta. 1463:2000;188-194.
174. Wanke M., Swiezewska E., Dallner G. Cell-free sorting of plastoquinone and ubiquinone in spinach cell. Plant Physiol. Biochem. 39:2001;467-472.
175. Santos-Ocana C., Do T.Q., Padilla S., Navas P., Clarke C.F. Uptake of exogenous coenzyme Q and transport to mitochondria is required for bc1 complex stability in yeast coq mutants. J. Biol. Chem. 277:2002;10973-10981.
176. Osowska-Rogers S., Swiezewska E., Andersson B., Dallner G. The endoplasmic reticulumn-Golgi system is a major site of plastoquinone synthesis in spinach leaves. Biochem. Biophys. Res. Commun. 205:1994;714-721.
177. Tekle M., Bentinger M., Nordman T., Appelkvist E.L., Chojnacki T., Olsson J.M. Ubiquinone biosynthesis in rat liver peroxisomes. Biochem. Biophys. Res. Commun. 291:2002;1128-1133.
178. Thompson S.L., Burrows R., Laub R.J., Krisans S.K. Cholesterol synthesis in rat liver peroxisomes. Conversion of mevalonic acid to cholesterol. J. Biol. Chem. 262:1987;17420-17425.
179. Appelkvist E.L., Kalen A. Biosynthesis of dolichol by rat liver peroxisomes. Eur. J. Biochem. 185:1989;503-509.
180. Grünler J., Parmryd I. Subcellular distribution of farnesyl protein transferase in rat liver. FEBS Lett. 455:1999;233-237.
181. van den Bosch H., Schutgens R.B., Wanders R.J., Tager J.M. Biochemistry of peroxisomes. Annu. Rev. Biochem. 61:1992;157-197.
182. Schägger H., Pfeiffer K. Supercomplexes in the respiratory chains of yeast and mammalian mitochondria. EMBO J. 19:2000;1777-1783.
183. Lenaz G. A critical appraisal of the mitochondrial coenzyme Q pool. FEBS Lett. 509:2001;151-155.
184. Asencio C., Rodríguez-Aguilera J.C., Ruiz-Ferrer M., Vela J., Navas P. Silencing of ubiquinone biosynthesis genes extends life span in Caenorhabditis elegans. FASEB J. 17:2003;1135-1137.
185. Faust J.R., Brown M.S., Goldstein J.L. Synthesis of delta 2-isopentenyl tRNA from mevalonate in cultured human fibroblasts. J. Biol. Chem. 255:1980;6546-6548.
186. Reiss Y., Brown M.S., Goldstein J.L. Divalent cation and prenyl pyrophosphate specificities of the protein farnesyltransferase from rat brain, a zinc metalloenzyme. J. Biol. Chem. 267:1992;6403-6408.
187. Willis R.A., Folkers K., Tucker J.L., Ye C.Q., Xia L.J., Tamagawa H. Lovastatin decreases coenzyme Q levels in rats. Proc. Natl. Acad. Sci. U. S. A. 87:1990;8928-8930.
188. Elmberger P.G., Kalen A., Lund E., Reihner E., Eriksson M., Berglund L., Angelin B., Dallner G. Effects of pravastatin and cholestyramine on products of the mevalonate pathway in familial hypercholesterolemia. J. Lipid Res. 32:1991;935-940.
189. Ericsson J., Thelin A., Chojnacki T., Dallner G. Substrate specificity of cis-prenyltransferase in rat liver microsomes. J. Biol. Chem. 267:1992;19730-19735.
190. Ghirlanda G., Oradei A., Manto A., Lippa S., Uccioli L., Greco A.V., Littarru G.P. Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study. J. Clin. Pharmacol. 33:1993;226-229.
191. Mortensen S.A., Leth A., Agner E., Rohde M. Dose-related decrease of serum coenzyme Q10 during treatment with HMG-CoA reductase inhibitors. Mol. Aspects Med. 18:1997;137-144.
192. Löw P., Andersson M., Edlund C., Dallner G. Effects of mevinolin treatment on tissue dolichol and ubiquinone levels in the rat. Biochim. Biophys. Acta. 1165:1992;102-109.
193. Thelin A., Peterson E., Hutson J.L., McCarthy A.D., Ericsson J., Dallner G. Effect of squalestatin 1 on the biosynthesis of the mevalonate pathway lipids. Biochim. Biophys. Acta. 1215:1994;245-249.
194. Keller R.K. Squalene synthase inhibition alters metabolism of nonsterols in rat liver. Biochim. Biophys. Acta. 1303:1996;169-179.
195. Machida K., Tanaka T. Farnesol-induced generation of reactive oxygen species dependent on mitochondrial transmembrane potential hyperpolarization mediated by F(0)F(1)-ATPase in yeast. FEBS Lett. 462:1999;108-112.
196. Machida K., Tanaka T., Yano Y., Otani S., Taniguchi M. Farnesol-induced growth inhibition in Saccharomyces cerevisiae by a cell cycle mechanism. Microbiology. 145:1999;293-299.
197. Correll C.C., Ng L., Edwards P.A. Identification of farnesol as the non-sterol derivative of mevalonic acid required for the accelerated degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J. Biol. Chem. 269:1994;17390-17393.
198. Morimoto H., Imada I., Goto G. Photooxidation of ubiquinone-7. Liebigs Ann. Chem. 735:1970;65-71.
199. Turunen M., Swiezewska E., Chojnacki T., Sindelar P., Dallner G. Regulatory aspects of coenzyme Q metabolism. Free Radic. Res. 36:2002;437-443.
200. Ramasarma T. Studies on ubiquinone. J. Sci. Ind. Res. 27:1968;147-164.
201. Aithal H.N., Joshi V.C., Ramasarma T. Effect of cold exposure on the metabolism of ubiquinone. Biochim. Biophys. Acta. 162:1968;66-72.
202. Joshi V.C., Jayaraman J., Ramasarma T. Tissue concentrations of coenzyme Q, ubichromenol and tocopherol in relation to protein status in the rat. Biochem. J. 88:1963;25-31.
203. Gohil K., Rothfuss L., Lang J., Packer L. Effect of exercise training on tissue vitamin E and ubiquinone content. J. Appl. Physiol. 63:1987;1638-1641.
204. Quiles J.L., Huertas J.R., Manas M., Battino M., Cassinello M., Littarru G.P., Lenaz G., Mataix F.J. Peroxidative extent and coenzyme Q levels in the rat: influence of physical training and dietary fats. Mol. Aspects Med. 15:1994;89-95.
205. Svensson M., Malm C., Tonkonogi M., Ekblom B., Sjödin B., Sahlin K. Effect of Q10 supplementation on tissue Q10 levels and adenine nucleotide catabolism during high-intensity exercise. Int. J. Sport Nutr. 9:1999;166-180.
206. Sohlenius-Sternbeck A.K., Appelkvist E.L., DePierre J.W. Effects of vitamin A deficiency on selected xenobiotic-metabolizing enzymes and defenses against oxidative stress in mouse liver. Biochem. Pharmacol. 59:2000;377-383.
207. Vadhanavikit S., Ganther H.E. Decreased ubiquinone levels in tissues of rats deficient in selenium. Biochem. Biophys. Res. Commun. 190:1993;921-926.
208. Navarro F., Navas P., Burgess J.R., Bello R.I., De Cabo R., Arroyo A., Villalba J.M. Vitamin E and selenium deficiency induces expression of the ubiquinone- dependent antioxidant system at the plasma membrane. FASEB J. 12:1998;1665-1673.
209. Zhang Y., Turunen M., Appelkvist E.L. Restricted uptake of dietary coenzyme Q is in contrast to the unrestricted uptake of alpha-tocopherol into rat organs and cells. J. Nutr. 126:1996;2089-2097.
210. Ibrahim W.H., Bhagavan H.N., Chopra R.K., Chow C.K. Dietary coenzyme Q10 and vitamin E alter the status of these compounds in rat tissues and mitochondria. J. Nutr. 130:2000;2343-2348.
211. Lass A., Forster M.J., Sohal R.S. Effects of coenzyme Q10 and α-tocopherol administration on their tissue levels in the mouse: elevation of mitochondrial a-tocopherol by coenzyme Q10. Free Radic. Biol. Med. 26:1999;1375-1382.
212. Åberg F., Appelkvist E.L., Bröijersen A., Eriksson M., Angelin B., Hjemdahl P., Dallner G. Gemfibrozil-induced decrease in serum ubiquinone and alpha- and gamma-tocopherol levels in men with combined hyperlipidaemia. Eur. J. Clin. Invest. 28:1998;235-242.
213. Guan Z., Söderberg M., Sindelar P., Prusiner S.B., Kristensson K., Dallner G. Lipid composition in scrapie-infected mouse brain: prion infection increases the levels of dolichyl phosphate and ubiquinone. J. Neurochem. 66:1996;277-285.
214. Shi H., Noguchi N., Niki E. Dynamics of antioxidant action of ubiquinol: a reappraisal. Biofactors. 9:1999;141-148.
215. Takahashi T., Yamaguchi T., Shitashige M., Okamoto M., Kishi T. Reduction of ubiquinone in membrane lipids by rat liver cytosol and its involvement in the cellular defence system against lipid peroxidation. Biochem. J. 309:1995;883-890.
216. Kishi T., Takahashi T., Usui A., Hashizume N., Okamoto T. Cytosolic NADPH-UQ reductase, the enzyme responsible for cellular ubiquinone redox cycle as an endogenous antioxidant in the rat liver. Biofactors. 9:1999;189-197.
217. Beyer R.E., Segura-Aguilar J., Di Bernardo S., Cavazzoni M., Fato R., Fiorentini D., Galli M.C., Setti M., Landi L., Lenaz G. The role of DT-diaphorase in the maintenance of the reduced antioxidant form of coenzyme Q in membrane systems. Proc. Natl. Acad. Sci. U. S. A. 93:1996;2528-2532.
218. Landi L., Fiorentini D., Galli M.C., Segura-Aguilar J., Beyer R.E. DT-Diaphorase maintains the reduced state of ubiquinones in lipid vesicles thereby promoting their antioxidant function. Free Radic. Biol. Med. 22:1997;329-335.
219. Lind C., Cadenas E., Hochstein P., Ernster L. DT-diaphorase: purification, properties, and function. Methods Enzymol. 186:1990;287-301.
220. Olsson J.M., Xia L., Eriksson L.C., Björnstedt M. Ubiquinone is reduced by lipoamide dehydrogenase and this reaction is potently stimulated by zinc. FEBS Lett. 448:1999;190-192.
221. Xia L., Björnstedt M., Nordman T., Eriksson L.C., Olsson J.M. Reduction of ubiquinone by lipoamide dehydrogenase. An antioxidant regenerating pathway. Eur. J. Biochem. 268:2001;1486-1490.
222. Xia L., Nordman T., Olsson J.M., Damdimopoulos A., Björkhem-Bergman L., Nalvarte I., Eriksson L.C., Arner E.S., Spyrou G., Björnstedt M. The mammalian cytosolic selenoenzyme thioredoxin reductase reduces ubiquinone. A novel mechanism for defense against oxidative stress. J. Biol. Chem. 278:2003;2141-2146.
223. Burleigh B.D., Williams C.H. The isolation and primary structure of a peptide containing the oxidation-reduction active cystine of Escherichia coli lipoamide dehydrogenase. J. Biol. Chem. 247:1972;2077-2082.
224. Ronchi S., Williams C.H. The isolation and primary structure of a peptide containing the oxidation-reduction active cystine of Escherichia coli thioredoxin reductase. J. Biol. Chem. 247:1972;2083-2086.
225. Krohne-Ehrich G., Schirmer R.H., Untucht-Grau R. Glutathione reductase from human erythrocytes. Isolation of the enzyme and sequence analysis of the redox-active peptide. Eur. J. Biochem. 80:1977;65-71.
226. Hayakawa T., Kanzaki T., Kitamura T., Fukuyoshi Y., Sakurai Y., Koike K., Suematsu T., Koike M. Mammalian alpha-keto acid dehydrogenase complexes: V. Resolution and reconstitution studies of the pig heart pyruvate dehydrogenase complex. J. Biol. Chem. 244:1969;3660-3670.
227. Kozlov A.V., Gille L., Staniek K., Nohl H. Dihydrolipoic acid maintains ubiquinone in the antioxidant active form by two-electron reduction of ubiquinone and one-electron reduction of ubisemiquinone. Arch. Biochem. Biophys. 363:1999;148-154.
228. Zhong L., Arner E.S., Holmgren A. Structure and mechanism of mammalian thioredoxin reductase: the active site is a redox-active selenolthiol/ selenenylsulfide formed from the conserved cysteine-selenocysteine sequence. Proc. Natl. Acad. Sci. U. S. A. 97:2000;5854-5859.
229. Zhang Y., Åberg F., Appelkvist E.L., Dallner G., Ernster L. Uptake of dietary coenzyme Q supplement is limited in rats. J. Nutr. 125:1995;446-453.
230. Yoshida H., Yusin M., Ren I., Kuhlenkamp J., Hirano T., Stolz A., Kaplowitz N. Identification, purification, and immunochemical characterization of a tocopherol-binding protein in rat liver cytosol. J. Lipid Res. 33:1992;343-350.
231. Kwong L.K., Kamzalov S., Rebrin I., Bayne A.C., Jana C.K., Morris P., Forster M.J., Sohal R.S. Effects of coenzyme Q(10) administration on its tissue concentrations, mitochondrial oxidant generation, and oxidative stress in the rat. Free Radic. Biol. Med. 33:2002;627-638.
232. Matthews R., Yang L., Brown S., Baik M., Beal F. Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proc. Natl. Acad. Sci. U. S. A. 95:1998;8892-8897.
233. Turunen M., Appelkvist E.L., Sindelar P., Dallner G. Blood concentration of coenzyme Q(10) increases in rats when esterified forms are administered. J. Nutr. 129:1999;2113-2118.
234. Burton G.W., Ingold K.U., Foster D.O., Cheng S.C., Webb A., Hughes L., Lusztyk E. Comparison of free α-tocopherol and α-tocopheryl acetate as sources of vitamin E in rats and humans. Lipids. 23:1988;834-840.
235. Elmberger P.G., Kalen A., Appelkvist E.L., Dallner G. In vitro and in vivo synthesis of dolichol and other main mevalonate products in various organs of the rat. Eur. J. Biochem. 168:1987;1-11.
236. Rötig A., Appelkvist E.L., Geromel V., Chretien D., Kadhom N., Edery P., Lebideau M., Dallner G., Munnich A., Ernster L., Rustin P. Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency. Lancet. 356:2000;391-395.
237. Nobuyoshi M., Saito T., Takahira H., Yamano Y., Kanazawa T. Levels of coenzyme Q10 in biopsies of left ventricular muscle and influence of administration of coenzyme Q10. Folkers K., Yamamura Y. Biomedical and Clinical Aspects of Coenzyme Q. vol. 4:1984;221-229 Elsevier, Amsterdam.
238. Kitamura N., Yamaguchi A., Otaki M., Sawatani O., Minoji T., Tamura H., Atobe M. Myocardial tissue level of coenzyme Q10 in patients with cardiac failure. Folkers K., Yamamura Y. Biomedical and Clinical Aspects of Coenzyme Q. vol. 4:1984;243-262 Elsevier, Amsterdam.
239. Folkers K., Vadahanavikit S., Mortensen S.A. Biochemical rationale and myocardial tissue data on the effective therapy of cardiomyopathy with coenzyme Q10. Proc. Natl. Acad. Sci. U. S. A. 82:1985;901-904.
240. Turunen M., Dallner G. Elevation of ubiquinone content by peroxisomal inducers in rat liver during aging. Chem. Biol. Interact. 116:1998;79-91.
241. Lenaz G., Fato R., Castelluccio C., Genova M.L., Bovina C., Estornell E., Valls V., Pallotti F., Castelli G.P. The function of coenzyme Q in mitochondria. Clin. Investig. 71:1993;66-70.
242. Thelin A., Schedin S., Dallner G. Half-life of ubiquinone-9 in rat tissues. FEBS Lett. 313:1992;118-120.
243. Andersson M., Elmberger P.G., Edlund C., Kristensson K., Dallner G. Rates of cholesterol, ubiquinone, dolichol and dolichyl-P biosynthesis in rat brain slices. FEBS Lett. 269:1990;15-18.
244. Wanke M., Swiezewska E., Dallner G. Half-life of ubiquinone and plastoquinone in spinach cells. Plant Sci. 154:2000;183-187.
245. Imada I., Watanabe M., Matsumoto N., Morimoto H. Metabolism of ubiquinone-7. Biochemistry. 9:1970;2870-2878.
246. Nakamura T., Ohno T., Hamamura K., Sato T. Metabolism of coenzyme Q10: biliary and urinary excretion study in guinea pigs. Biofactors. 9:1999;111-119.
247. Burchell B., Coughtrie M.W. UDP-glucuronosyltransferases. Pharmacol. Ther. 43:1989;261-289.
248. DePierre J.W., Sohlenius A.K., Cai Y., Eriksson A.M., Andersson K., Sundberg C. Peroxisome proliferation in response to xenobiotics. Biochem. Soc. Trans. 23:1995;425-429.
249. Reddy J.K., Chu R. Peroxisome proliferator-induced pleiotropic responses: pursuit of a phenomenon. Ann. N.Y. Acad. Sci. 804:1996;176-201.
250. Bentley P., Calder I., Elcombe C., Grasso P., Stringer D., Wiegand H.J. Hepatic peroxisome proliferation in rodents and its significance for humans. Food Chem. Toxicol. 31:1993;857-907.
251. Åberg F., Zhang Y., Appelkvist E.L., Dallner G. Effects of clofibrate, phthalates and probucol on ubiquinone levels. Chem. Biol. Interact. 91:1994;1-14.
252. Åberg F., Zhang Y., Teclebrhan H., Appelkvist E.L., Dallner G. Increases in tissue levels of ubiquinone in association with peroxisome proliferation. Chem. Biol. Interact. 99:1996;205-218.
253. Turunen M., Peters J.M., Gonzalez F.J., Schedin S., Dallner G. Influence of peroxisome proliferator-activated receptor alpha on ubiquinone biosynthesis. J. Mol. Biol. 297:2000;607-614.
254. Bentinger M., Turunen M., Zhang X.X., Wan Y.J., Dallner G. Involvement of retinoid X receptor alpha in coenzyme Q metabolism. J. Mol. Biol. 326:2003;795-803.
255. Barnett P., Tabak H.F., Hettema E.H. Nuclear receptors arose from pre-existing protein modules during evolution. Trends Biochem. Sci. 25:2000;227-228.
256. Khorasanizadeh S., Rastinejad F. Nuclear-receptor interactions on DNA-response elements. Trends Biochem. Sci. 26:2001;384-390.
257. Issemann I., Green S. Activation of a member of the steroid hormone receptor superfamiliy by peroxisome proliferators. Nature. 347:1990;645-650.
258. Gronemeyer H. Control of transcription activation by steroid hormone receptors. FASEB J. 6:1992;2524-2529.
259. Wahli W., Braissant O., Desvergne B. Peroxisome proliferator activated receptors: transcriptional regulators of adipogenesis, lipid metabolism and more. Chem. Biol. 2:1995;261-266.
260. Frohnert B.I., Hui T.Y., Bernlohr D.A. Identification of a functional peroxisome proliferator-responsive element in the murine fatty acid transport protein gene. J. Biol. Chem. 274:1999;3970-3977.
261. Hunt M.C., Ynag Y.-Z., Eggertsen G., Carnheim C.M., Gåfvels M., Einarsson C., Alexson S.E. The peroxisome proliferator-activated receptor α (PPARα) regulates bile acid synthesis. J. Biol. Chem. 275:2000;28947-28953.
262. Yu V.C., Delsert C., Andersen B., Holloway J.M., Devary O.V., Naar A.M., Kim S.Y., Boutin J.M., Glass C.K., Rosenfeld M.G. RXR beta: a coregulator that enhances binding of retinoic acid, thyroid hormone and vitamin D receptors to their cognate response elements. Cell. 67:1991;1251-1266.
263. Kliewer S.A., Umensono K., Mangelsdorf D.J., Evans R.M. Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signaling. Nature. 355:1992;446-449.
264. Kliever S.A., Umensono K., Noonan D.J., Heyman R.A., Evans R.M. Convergence of 9-cis retionic acid and peroxisome proliferator signaling pathways through heterodimer formation of their receptors. Nature. 358:1992;771-774.
265. Forman B.M., Umesono K., Chen J., Evans R.M. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell. 81:1995;541-550.
266. Umesono K., Murakami K.K., Thompson C.C., Evans R.M. Direct repeats as selective response elements for the thyroid hormone, retinoic acid and vitamin D receptors. Cell. 65:1991;1255-1266.
267. Hörlein A.J., Näär A.M., Heinzel T., Torchia J., Gloss B., Kurokawa R., Ryan A., Kamei Y., Söderström M., Glass C.K., Rosenfeld M.G. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature. 377:1995;397-404.
268. Lee S.S., Pineau T., Drago J., Lee E.J., Owens J.W., Kroetz D.L., Fernandez-Salguero P.M., Westphal H., Gonzalez F.J. Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol. 15:1995;3012-3022.
269. Lemberger T., Braissant O., Juge-Aubry C., Keller H., Saladin R., Staels B., Auwerx J., Burger A.G., Meier C.A., Wahli W. PPAR tissue distribution and interactions with other hormone-signaling pathways. Ann. N.Y. Acad. Sci., U. S. A. 804:1996;231-251.
270. Wan Y.J., An D., Cai Y., Repa J.J., Hung-Po Chen T., Flores M., Postic C., Magnuson M.A., Chen J., Chien K.R., French S., Mangelsdorf D.J., Sucov H.M. Hepatocyte-specific mutation establishes retinoid X receptor alpha as a heterodimeric integrator of multiple physiological processes in the liver. Mol. Cell. Biol. 20:2000;4436-4444.
271. Wan Y.-J.Y., Cai Y., Lungo W., Fu P., Locker J., French S., Sucov H.M. Peroxisome proliferator-activated receptor α-mediated pathways are altered in hepatocyte-specific retinoid X receptor α-deficient mice. J. Biol. Chem. 275:2000;28285-28290.
272. Larsen P.L., Clarke C.F. Extension of life-span in Caenorhabditis elegans by a diet lacking coenzyme Q. Science. 295:2002;120-123.
273. Lönnrot K., Metsa-Ketela T., Alho H. The role of coenzyme Q-10 in aging: a follow-up study on life-long oral supplementation Q-10 in rats. Gerontology. 41:1995;109-120.
274. Lönnrot K., Holm P., Lagerstedt A., Huhtala H., Alho H. The effects of lifelong ubiquinone Q10 supplementation on the Q9 and Q10 tissue concentrations and life span of male rats and mice. Biochem. Mol. Biol. Int. 44:1998;727-737.
275. Kalen A., Appelkvist E.L., Dallner G. Age-related changes in the lipid compositions of rat and human tissues. Lipids. 24:1989;579-584.
276. Battino M., Gorini A., Villa R.F., Genova M.L., Bovina C., Sassi S., Littarru G.P., Lenaz G. Coenzyme Q content in synaptic and non-synaptic mitochondria from different brain regions in the rat. Mech. Ageing Dev. 78:1995;173-187.
277. Genova M.L., Castelluccio C., Fato R., Parenti Castelli G., Merlo Pinch M., Formiggini G., Bovina C., Marchetti M., Lenaz G. Major changes in complex I activity in mitochondria from aged rats may not be detected by direct assay of NADH:coenzyme Q reductase. Biochem. J. 311:1995;105-109.
278. Lass A., Kwong L., Sohal R.S. Mitochondrial coenzyme Q content and aging. Biofactors. 9:1999;199-205.
279. Folkers K., Littarru G.P., Nakamura R., Scholler J. Survey and new clinical studies on coenzyme Q in human muscular dystrophy. Int. J. Vitam. Nutr. Res. 42:1972;139-163.
280. Folkers K. Heart failure is a dominant deficiency of coenzyme Q10 and challenges for future clinical research on CoQ10. Clin. Invest. 71:1993;51-54.
281. Ogasahara S., Engel A.G., Frens D., Mack D. Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy. Proc. Natl. Acad. Sci. U. S. A. 86:1989;2379-2382.
282. Manzoli U., Rossi E., Littarru G.P., Frustaci A., Lippa S., Oradei A., Aureli V. Coenzyme Q10 in dilated cardiomyopathy. Int. J. Tissue React. 12:1990;173-178.
283. Langsjoen P.H., Langsjoen A.M. Overview of the use of CoQ10 in cardiovascular disease. Biofactors. 9:1999;273-284.
284. Olsson J.M., Eriksson L.C., Dallner G. Lipid compositions of intracellular membranes isolated from rat liver nodules in Wistar rats. Cancer Res. 51:1991;3774-3780.
285. Olsson J.M., Schedin S., Teclebrhan H., Eriksson L.C., Dallner G. Enzymes of the mevalonate pathway in rat liver nodules induced by 2-acetylaminofluorene treatment. Carcinogenesis. 16:1995;599-605.
286. Dröge W. Free radicals in the physiological control of cell function. Physiol. Rev. 82:2002;47-95.
287. Eggens I., Elmberger P.G., Löw P. Polyisoprenoid, cholesterol and ubiquinone levels in human hepatocellular carcinomas. Br. J. Exp. Pathol. 70:1989;83-92.
288. Barbiroli B., Frassineti C., Martinelli P., Iotti S., Lodi R., Cortelli P., Montagna P. Coenzyme Q10 improves mitochondrial respiration in patients with mitochondrial cytopathies. An in vivo study on brain and skeletal muscle by phosphorous magnetic resonance spectroscopy. Cell. Mol. Biol. 43:1997;741-749.
289. Koroshetz W.J., Jenkins B.G., Rosen B.R., Beal M.F. Energy metabolism defects in Huntington's disease and effects of coenzyme Q10. Ann. Neurol. 41:1997;160-165.
290. Shults C.W., Haas R.H., Passov D., Beal M.F. Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects. Ann. Neurol. 42:1997;261-264.
291. Beal M.F., Matthews R.F. Coenzyme Q10 in the central nervous system and its potential usefulness in the treatment of neurodegenerative diseases. Mol. Aspects Med. 18:1997;169-179.
292. Shults C.W., Oakes D., Kieburtz K., Beal M.F., Haas R., Plumb S., Juncos J.L., Nutt J., Shoulson I., Carter J., Kompoliti K., Perlmutter J.S., Reich S., Stern M., Watts R.L., Kurlan R., Molho E., Harrison M., Lew M. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch. Neurol. 59:2002;1541-1550.
293. Söderberg M., Edlund C., Alafuzoff I., Kristensson K., Dallner G. Lipid composition in different regions of the brain in Alzheimer's disease/senile dementia of Alzheimer's type. J. Neurochem. 59:1992;1646-1653.
294. Contestabile A. Oxidative stress in neurodegeneration: mechanisms and therapeutic perspectives. Curr. Top. Med. Chem. 1:2001;553-568.
295. Prusiner S.B. Prions. Proc. Natl. Acad. Sci. U. S. A. 95:1998;13363-13383.
296. Schedin S., Pentchev P., Dallner G. Reduced cholesterol accumulation and improved deficient peroxisomal functions in a murine model of Niemann-Pick type C disease upon treatment with peroxisomal proliferators. Biochem. Pharmacol. 56:1998;1195-1199.
297. Palmeira C.M., Santos D.L., Seica R., Moreno A.J., Santos M.S. Enhanced mitochondrial testicular antioxidant capacity in Goto-Kakizaki diabetic rats: role of coenzyme Q. Am. J. Physiol., Cell Physiol. 281:2001;1023-1028.
298. J. Grünler, Compartmentalization of lipid metabolism in rat liver, PhD thesis. Stockholm University, 2000.
299. Inoue I., Goto S., Mizotani K., Awata T., Mastunaga T., Kawai S., Nakajima T., Hokari S., Komoda T., Katayama S. Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect: reduction of mRNA levels for interleukin-1beta, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor alpha (PPARalpha) in primary endothelial cells. Life Sci. 67:2000;863-876.
300. Walravens P.A., Greene C., Freeman F.E. Lovastatin, isoprenes, and myopathy. Lancet. 2:1989;1097-1098.
301. Ericsson J., Dallner G. Distribution, biosynthesis, and function of mevalonate pathway lipids. Sub cell. Biochem. 21:1993;229-272.
302. Yamashita S., Yamamoto Y. Simultaneous detection of ubiquinol and ubiquinone in human plasma as a marker of oxidative stress. Anal. Biochem. 250:1997;66-73.
303. Yamamoto Y., Wakabayashi K., Nikki E., Nagao M. Comparison of plasma levels of lipid hydroperoxides and antioxidants in hyperlipidemic Nagase analbuminemic rats, Sprague-Dawley rats, and humans. Biochem. Biophys. Res. Commun. 189:1992;518-523.
304. Yamamoto Y., Yamashita S., Fujisawa A., Kokura S., Yoshikawa T. Oxidative stress in patients with hepatitis, cirrhosis, and hepatoma evaluated by plasma antioxidants. Biochem. Biophys. Res. Commun. 247:1998;166-170.
305. Ashby M.N., Edwards P.A. Elucidation of the deficiency in two yeast coenzyme Q mutants: characterization of the structural gene encoding hexaprenyl pyrophosphate synthetase. J. Biol. Chem. 265:1990;13157-13164.
306. Suzuki K., Okada K., Kamiya Y., Zhu X.F., Nakagawa T., Kawamukai M., Matsuda H. Analysis of the decaprenyl diphosphate synthase (dps) gene in fission yeast suggests a role of ubiquinone as an antioxidant. J. Biochem. (Tokyo). 121:1997;496-505.
307. Asai K., Fujisaki S., Nishimura Y., Nishino T., Okada K., Nakagawa T., Kawamukai M., Matsuda H. The identification of Escherichia coli ispB (cel) gene encoding the octaprenyl diphosphate synthase. Biochem. Biophys. Res. Commun. 202:1994;340-345.
308. Uchida N., Suzuki K., Saiki R., Kainou T., Tanaka K., Matsuda H., Kawamukai M. Phenotypes of fission yeast defective in ubiquinone production due to disruption of the gene for p-hydroxybenzoate polyprenyl diphosphate transferase. J. Bacteriol. 182:2000;6933-6939.
309. Siebert M., Bechthold A., Melzer M., May U., Berger U., Schroder G., Schroder J., Severin K., Heide L. Ubiquinone biosynthesis. Cloning of the genes coding for chorismate pyruvate-lyase and 4-hydroxybenzoate octaprenyl transferase from Escherichia coli. FEBS Lett. 307:1992;347-350.
310. Bousquet I., Dujardin G., Slonimski P.P. ABC1, a novel yeast nuclear gene has a dual function in mitochondria: it suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex. EMBO J. 10:1991;2023-2031.
311. Cox G.B., Young I.G., McCann L.M., Gibson F. Biosynthesis of ubiquinone in Escherichia coli K-12: location of genes affecting the metabolism of 3-octaprenyl-4-hydroxybenzoic acid and 2- octaprenylphenol. J. Bacteriol. 99:1969;450-458.
312. Zeng H., Snavely I., Zamorano P., Javor G.T. Low ubiquinone content in Escherichia coli causes thiol hypersensitivity. J. Bacteriol. 180:1998;3681-3685.
313. Nakahigashi K., Miyamoto K., Nishimura K., Inokuchi H. Isolation and characterization of a light-sensitive mutant of Escherichia coli K-12 with a mutation in a gene that is required for the biosynthesis of ubiquinone. J. Bacteriol. 174:1992;7352-7359.
314. Barkovich R.J., Shtanko A., Shepherd J.A., Lee P.T., Myles D.C., Tzagoloff A., Clarke C.F. Characterization of the COQ5 gene from Saccharomyces cerevisiae. Evidence for a C-methyltransferase in ubiquinone biosynthesis. J. Biol. Chem. 272:1997;9182-9188.
315. Lee P.T., Hsu A.Y., Ha H.T., Clarke C.F. A C-methyltransferase involved in both ubiquinone and menaquinone biosynthesis: isolation and identification of the Escherichia coli ubiE gene. J. Bacteriol. 179:1997;1748-1754.
316. Kwon O., Kotsakis A., Meganathan R. Ubiquinone (coenzyme Q) biosynthesis in Escherichia coli: identification of the ubiF gene. FEMS Microbiol. Lett. 186:2000;157-161.
317. Morré D.M., Lenaz G., Morré D.J. Surface oxidase and oxidative stress propagation in aging. J. Exp. Biol. 203:2000;1513-1521.